Medical Xpress·3 min read·medium
Inflammation may drive Dravet syndrome, offering a potential new treatment target
W
Weill Cornell Medical College
✦AI Summary
Researchers at Weill Cornell Medicine have identified that an overactive immune response, specifically the cGAS-STING-interferon pathway, may drive Dravet syndrome. This discovery suggests that targeting inflammation could provide a new therapeutic approach for this severe form of childhood epilepsy.
edited by Lisa Lock , reviewed by Robert Egan
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in